Estramustine Phosphate Therapy in Carcinoma of the Prostate
- 1 January 1977
- book chapter
- Published by Springer Nature
- No. 60,p. 73-77
- https://doi.org/10.1007/978-3-642-81095-4_7
Abstract
Estramustine phosphate in the treatment of prostatic carcinoma was introduced in 1966. The substance is an estradiol-17-β-phosphate which is esterified with nor nitrogen mustard as a carbamate. It has become known under the trade name Estracyt.Keywords
This publication has 1 reference indexed in Scilit:
- Treatment of Prostatic Carcinoma with Various Types of Estrogen DerivativesPublished by Elsevier ,1976